Psychemedics Corporation Reports First Quarter 2024 Financial Results
Psychemedics Corporation Reports First Quarter 2024 Financial Results
DALLAS, May 14, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world's leading provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2024.
達拉斯，2024年5月14日（GLOBE NEWSWIRE）——全球領先的濫用藥物毛髮測試提供商Psychemedics Corporation（納斯達克股票代碼：PMD）今天公佈了截至2024年3月31日的第一季度財務業績。
The Company's revenue for the quarter ended March 31, 2024, was $5.4 million versus $5.9 million for the quarter ended March 31, 2023, a decrease of 9%. Net loss for the quarter was $0.7 million, or $0.12 per share, compared to a net loss of $0.4 million, or $.07 per share, for the comparable quarter last year.
截至2024年3月31日的季度，該公司的收入爲540萬美元，而截至2023年3月31日的季度收入爲590萬美元，下降了9％。該季度的淨虧損爲70萬美元，合每股虧損0.12美元，而去年同期的淨虧損爲40萬美元，合每股虧損0.07美元。
Brian Hullinger, President, and Chief Executive Officer, stated:
總裁兼首席執行官布萊恩·哈林格表示：
"Although we experienced a decrease in revenues and earnings for the quarter, we remain optimistic about the future. We continue to actively explore new markets and applications for our hair testing solutions. With a renewed focus on client acquisition, we are confident we are positioning the Company first for revenue stabilization and then for growth."
“儘管我們經歷了本季度的收入和收益下降，但我們對未來仍然持樂觀態度。我們將繼續積極探索我們的頭髮測試解決方案的新市場和應用。隨着重新關注客戶獲取，我們有信心將公司首先定位爲收入穩定，然後實現增長。”
譯文內容由第三人軟體翻譯。